ACH: Q3 underperformance prompts an operational turnaround and a sharp reduction to FY 2026 EBITDA expectationsQuartr·Nov 5, 2026 at 11:41 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences falls 7% during regular tradingMarket Movers·Nov 2, 2026 at 03:59 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences falls 6% during regular tradingMarket Movers·Oct 30, 2026 at 04:12 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences Reports 31.2% Quit Rate in 52-Week Cytisinicline TrialPUBT·Oct 21, 2026 at 12:33 PMACHV0.00%QUIT-5.60%
Biotech Sector Navigates Clinical Inflection Points Amid Revenue DivergenceGlobal Report·Oct 21, 2026 at 10:13 AMDNA-2.91%JSPR-9.90%
Mining Profits Flip Positive as Retail, Finance Giants Overhaul Payment and Regulatory StrategiesGlobal Report·Oct 13, 2026 at 10:15 AMPSQH-41.07%TMQ-6.93%
Achieve Life Sciences appoints Kaitlyn Tuson SVP marketing, communicationsPUBT·Oct 7, 2026 at 12:32 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences CFO Benjamin Halladay files initial beneficial ownership statementPUBT·Oct 6, 2026 at 08:14 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences grants CFO Benjamin Halladay inducement equity awards for 400,000 sharesPUBT·Oct 6, 2026 at 08:02 PMACHV0.00%QUIT-5.60%
Achieve Life Sciences names Benjamin Halladay CFO, effective Oct. 5PUBT·Oct 1, 2026 at 12:32 PMACHV0.00%QUIT-5.60%
